
Loading, please wait...

Loading, please wait...

Researchers have recently isolated several bioactive compounds from the fruits of Hypericum patulum, a plant commonly known as Goldencup St. John’s Wort. This discovery highlights the potential of Hypericum patulum anticancer activity in the ongoing search for natural therapeutic agents. The study identified twenty-eight prenylated acylphloroglucinols, including four novel compounds termed hypulatones C-F.
Among the newly discovered molecules, Compound 1 is particularly noteworthy as a rare meroterpenoid. It forms through the unique addition of a prenylated acylphloroglucinol unit to a sesquiterpenoid moiety. Furthermore, Compound 2, a spirocyclic polycyclic polyprenylated acylphloroglucinol, contains six chiral centers. Scientists established its relative configuration using advanced conformational analysis and NOE correlations. These structural complexities often correlate with specific biological interactions within human cells.
To assess the therapeutic potential of these isolates, the research team performed cytotoxic evaluations using the CCK-8 assay. They specifically tested the compounds against two human carcinoma cell lines: Huh-7 (hepatocellular carcinoma) and Panc-1 (pancreatic cancer). Consequently, the results revealed that compounds 6, 8, and 15 exhibited moderate antiproliferative activity. While these findings are preliminary, they provide a foundation for developing targeted natural therapies against challenging gastrointestinal malignancies.
Prenylated acylphloroglucinols (PPAPs) are a diverse class of plant secondary metabolites, primarily found in the Hypericum genus. They are known for their complex chemical structures and a wide range of biological activities, including antimicrobial and antitumor properties.
Huh-7 and Panc-1 are standard laboratory cell lines used to study liver and pancreatic cancers, respectively. Researchers use these models to screen for compounds that can effectively inhibit the growth of aggressive tumor cells.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Qiu YF et al. Prenylated acylphloroglucinols from the fruits of Hypericum patulum. Nat Prod Bioprospect. 2026 Apr 23. doi: undefined. PMID: 42020892.
Wu ZN et al. Hyperpatulones A–F, polycyclic polyprenylated acylphloroglucinols from Hypericum patulum and their cytotoxic activities. RSC Adv. 2019;9:8191-8199.
Qi CX et al. Hyparillums A and B: polycyclic polyprenylated acylphloroglucinols from Hypericum patulum. Chin J Nat Med. 2024;22(3):273-279.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New research isolates 28 compounds from Hypericum patulum, showing moderate antiproliferative activity against liver and pancreatic carcinoma cell lines....
4 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today